ORGO Q1 2018 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$1M

Net Income

-$135,653

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$226,393

Free Cash Flow

-$226,393

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$314M

Total Liabilities

$16M

Stockholders' Equity

$298M

Cash & Equivalents

$99,493

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$218,648	-430.0%
Operating Income	-$1M	-$218,648	-430.0%
Net Income	-$135,653	$140,863	-196.3%